Nebivolol Protects against Myocardial Infarction Injury via Stimulation of Beta 3-Adrenergic Receptors and Nitric Oxide Signaling

Nebivolol, third-generation β-blocker, may activate β3-adrenergic receptor (AR), which has been emerged as a novel and potential therapeutic targets for cardiovascular diseases. However, it is not known whether nebivolol administration plays a cardioprotective effect against myocardial infarction (M...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zheng, Ding, Liping, Jin, Zhitao, Gao, Guojie, Li, Huijun, Zhang, Lijuan, Zhang, Lina, Lu, Xin, Hu, Lihua, Lu, Bingwei, Yu, Xiongjun, Hu, Taohong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029889/
https://www.ncbi.nlm.nih.gov/pubmed/24849208
http://dx.doi.org/10.1371/journal.pone.0098179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029889/
https://www.ncbi.nlm.nih.gov/pubmed/24849208
http://dx.doi.org/10.1371/journal.pone.0098179

Ejemplares similares